About Ador Diagnostics
ADOR Diagnostics develops and manufactures groundbreaking in-vitro multiplex molecular diagnostic solutions designed to immediately diagnose various medical conditions.
The company focuses now on the development of the NATlab system, an innovative solution for rapid and accurate infectious disease diagnostics at near patient setting. The system is comprised of a new IP-protected sensor technology with multiple detection spots, sample-to-answer microfluidic cartridge and IP-protected isothermal molecular amplification. The NATlab system offers a revolutionary syndromic molecular detection system for infectious diseases as well as other medical conditions.
The company is based in Cyprus with operations in Israel and Italy.
ADOR Management Team
Dr. Zvi Marom
Chairman
Zvi is the Founder and former CEO of publicly traded BATM. Zvi holds several board positions with national and international academic committees and was the Chairman of the Board of the Israeli Hi-Tech & Innovation Industries Association of Israel.
Dr. Eran Zahavy
CEO
Eran has nearly 20 years of leading R&D positions for chemistry, biology, biophysics and IVD in Israel Inst.
For Biological Research (IIBR)
and as VP for Innovation and BD. Eran as served as CTO of “Hutchison-
Kinorot” incubator and Longliv VC.
Eran holds a PhD in chemistry & biophysics from the Hebrew University and a Post Doc from the University of Texas, Austin.
Dr. Vladimir Hurgin
VP R&D
Vladimir graduated with his PhD at the Department of Molecular Genetics at
Weizmann Institute of Science (Israel).
Vladimir continued his research on interferon and cytokine molecular biology as a Post Doctoral Fellow and as a Staff Scientist at Weizmann Institute of Science.
ADOR Advisory Board
Nadhim Zahawi
Chairman of Advisory Board
The Rt. Hon Nadhim Zahawi is a businessman who served in the British Government as, inter alia, Chancellor of the Exchequer, Vaccine Deployment Minister, and Member of Parliament for Stratford-on-Avon.
After graduating from University College London with a degree in chemical engineering, Nadhim worked in business before founding one of the world’s largest and most successful polling and market research companies, YouGov, in 2000.
He was CEO of YouGov until 2010, when he stood down to become the Member of Parliament for Stratford-on-Avon, birthplace of William Shakespeare where he served until standing down in 2024. His most notable successes include leading the UK's world-beating COVID vaccination rollout, keeping schools open during the omicron wave, and coordinating Her Late Majesty Queen Elizabeth II's funeral.
Prof. Matthew Fisher
Professor of Fungal Disease Epidemiology, Imperial College London, UK.
Prof Matthew Fisher works on emerging pathogenic fungi.
His research uses an evolutionary framework to investigate the biological and environmental factors that are driving emerging fungal diseases across human, wildlife and plant species.
Matthew Fisher’s research group is focused on research using genomic, epidemiological, ecological and experimental analysis to attempt to develop new methods of diagnosis and control
Prof. Avigdor Shafferman
CEO (Ret.) Israel Institute of Biological Research.
Dr. Avigdor Shafferman holds a Ph.D. in physical chemistry from the Hebrew University of Jerusalem.
He was a visiting professor in the University of California, San Diego at the biology department as well as a visiting senior research scientist at various leading research institutions in the United States in various medical areas including vaccines.
Prof. Sadik Esener
Sadik Esener, Ph.D., is the director of the Cancer Early Detection Advanced Research center and Wendt Family Endowed Chair in Early Cancer Detection at the Biomedical Engineering Department at OHSU. He served as the director and principal investigator of the NanoTumor Cancer, a Nanotechnology Center of Excellence funded by the National Cancer Institute. He has also held leadership roles with the Center for Heterogeneously Integrated Photonics Systems (CHIPS) as well as the Opto-Electronic Stacked Processors (OESP) and the Fast Read-out Optical Data Storage Industrial Consortium, which were both funded by DARPA.
Esener received his Ph.D. in applied physics and electrical engineering from the Universtiy of California, San Diego. He has published more than 375 journal and conferences articles. Esener co-founded and served on the board of directors and scientific advisory boards of several companies.
Prof. Shevin Jacobs
Dr Shevin Jacob is a US-trained infectious diseases consultant who started as an LSTM faculty member in 2017 with a primary mandate to develop and lead sepsis research initiatives in low- and middle-income countries. He obtained a Doctorate of Medicine (MD) degree at Oregon Health & Sciences University and a Masters in Public Health (MPH) degree from the Harvard School of Public Health. He underwent his post-graduate training at the University of Virginia (internal medicine) and University of Washington (infectious diseases). After completion of his infectious diseases specialty training in 2012, he remained at University of Washington as faculty within the Division of Allergy and Infectious Diseases in the Department of Medicine; he maintains an affiliate faculty appointment at University of Washington.